Top Tech Startups in Cambridge, MA in 2026

LogicMonitor®’s SaaS-based observability and IT operations data collaboration platform helps ITOps, developers, MSPs and business leaders gain visibility into and predictability across the technologies that modern organizations depend on to deliver extraordinary employee and customer experiences. LogicMonitor seamlessly monitors everything from networks to applications to the cloud, empowering companies to focus less on troubleshooting and more on innovation. For more information, visit logicmonitor.com. Great Place to Work Certified, 2022 Best Places to Work, Built in Austin 2022 Company with the Best Benefits, Built in Austin 2022

Topsort is the leading AI and Auction-based retail media global company, transforming retailers and marketplaces into top ad networks on par with industry giants. Through seamless integration, Topsort provides a comprehensive Bidless™ retail media tech stack featuring highly flexible API tools, an industry-leading privacy-safe clean room with robust online and in-store attribution, and a transparent ad network for streamlined media buying across multiple ad networks. In just three years since launch, Topsort has raised $38 million in funding from investors like Pear Ventures, Quiet Capital, FJ Labs, and Upload Ventures.

Google’s mission is to organize the world’s information and make it universally accessible and useful.

Ark is building the world’s highest-fidelity bioprocess simulation software to help life-saving therapies reach patients faster. By democratizing complex AI x multi-physics models in an intuitive software interface, we are transforming how bioprocess scientists work.

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.

We combine expert curation and unmatched value to connect readers with books they’ll love. We believe that discovering, buying, marketing, and selling books online should always be an easy, joyful experience. We lean into two key concepts – expert curation and unmatched value – to build innovative products and tools that get the right books into the right hands. Our teams at BookBub and Chirp have helped the publishing industry drive hundreds of millions of dollars in ebook and audiobook sales worldwide – and every day, millions of readers turn to us for help finding books they’ll love.

Compa is a venture-backed SaaS startup revolutionizing the future of compensation. In a dynamic job market with hiring challenges, accountability, and the rise of AI, companies need the best data to stay ahead of industry changes, competition, and costs. Compa has developed the premier real-time compensation data platform, delivering top-tier compensation intelligence to leading enterprise teams. Compa is a compensation intelligence company built to augment enterprise compensation teams in the era of AI. Our customers include the world’s biggest companies: Apple, NVIDIA, Tesla, Mastercard, T-Mobile, Sanofi, Moderna, Gilead Sciences, and more.

Our AI powered platform uniquely supercharges B2B distributors sales through three channels: reps, email and e-commerce. By understanding which customers are likely to purchase each product and when, from new items to items which are frequently re-ordered our AI is able to direct sales reps on which customers to talk with and about what products. We also allow companies to send targeted emails tailored to each customer which sync with the messaging from the sales team. Finally, our customers customers get a personalized buying experience online. At one enterprise customer, we increased rep effectiveness by 9x in a control trial. At another customer, we are projected to drive a 10% increase in revenue with one year of use of our product. Reps love using our platform, saying it “makes me a killer.”

Our first product is an automated hair braider that reduces appointment times from hours to minutes, empowering stylists to triple their business and addressing the 8 billion hours spent braiding hair each year.

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.